fbpx

World Pharma News

21

Jun2021
Pfizer’s JAK inhibitor Xeljanz reduced the risk of severe outcomes in hospitalised adult patients with COVID-19 pneumonia who ... Read More

21

Jun2021
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved Astepro® Allergy (Azelastine ... Read More

21

Jun2021
Market research suggests the new drug patent reforms in China, in addition to other regulatory changes, will incentivise ... Read More

21

Jun2021
Bristol-Myers Squibb Co and Eisai Co said on Thursday they had entered into an agreement worth up to ... Read More
X
Send a message
Request a call

    * Required fields

    By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      * Required fields

      By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      X